Trials / Conditions / Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
3 registered clinical trials studyying Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin NCT05202782 | Northwestern University | Phase 2 |
| Suspended | Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag NCT04799275 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Active Not Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho NCT03038672 | National Cancer Institute (NCI) | Phase 2 |